Review links hearing aid devices with reduced cognitive decline
Dec 06, 2022
Further, the use of devices is linked to a 3% improvement in cognitive test scores in the short term.
United States to end mpox public health emergency in January
Dec 05, 2022
More than 29,000 Americans contracted the virus, and 17 died during, an outbreak that started earlier this year.
Legalization of medical marijuana beneficial for cancer patients
Dec 05, 2022
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Bevacizumab, aflibercept compared for neovascular AMD
Dec 05, 2022
At the end of one year, the likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab.
Poor sleep tied to urinary, prostate symptoms
Dec 05, 2022
The association was especially strong among the elderly male population.
Herpes zoster linked to increased risk for cardiovascular disease events
Dec 02, 2022
The long-term risks for stroke and coronary heart disease increased for individuals with a history of herpes zoster versus those with no history of herpes zoster.
Deferiprone not beneficial for newly diagnosed Parkinson’s disease
Dec 01, 2022
“Deferiprone was not associated with benefit as compared with placebo in measures of the progression of Parkinson’s disease, and there was evidence of clinical worsening,” the authors...
Subjective cognitive decline tied to incident dementia in Black, Latinx individuals
Dec 01, 2022
Subjective cognitive decline was associated with increased rates of incident dementia over time in the multiracial population, Latinx and non-Latinx Black individuals.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Overactive bladder common in postacute COVID-19 syndrome
Nov 30, 2022
COVID-19 may lead to new or worsening urinary symptoms in men and women.